Glipden-M2 1000

Metformin Glimepiride Tablets combine two antidiabetic ingredients that work through different mechanisms to support blood glucose management in adults with type 2 diabetes mellitus.

📋 COMPOSITION
Metformin Hydrochloride (Prolonged Release) 1000mg + Glimepiride 2mg

💊 DOSAGE FORM
Tablet

📦 PACKAGING TYPE
Blister

🗃️ PACKAGING
10×10

Description

Metformin Glimepiride Tablets combine two antidiabetic medicines that work through different mechanisms to support blood glucose management in adults with type 2 diabetes mellitus. Glipden-M2 1000 contains Metformin Hydrochloride 1000 mg in a prolonged-release formulation and Glimepiride 2 mg.

Metformin helps reduce glucose production in the liver and improves the body’s response to insulin. Glimepiride stimulates insulin release from the pancreas. Together, these ingredients may help improve glycaemic control when prescribed by a qualified healthcare professional.

Glipden-M2 1000 belongs to the Cardries Biotic product range by Neuark Pharmaceutical. It is supplied in a blister pack of 10 × 10 tablets.

For more pharmaceutical products, explore the Neuark Pharmaceutical product range.

Therapeutic Segment

Antidiabetic – Type 2 Diabetes Management

Metformin Glimepiride Tablets belong to the antidiabetic therapeutic segment. Healthcare professionals may prescribe this combination when both ingredients are considered appropriate for managing blood glucose levels in adults with type 2 diabetes.

Uses of Metformin Glimepiride Tablets

Glipden-M2 1000 may be prescribed by a healthcare professional for:

  • Supporting blood glucose management in adults with type 2 diabetes mellitus.
  • Helping improve glycaemic control as part of an overall diabetes management plan.
  • Combining the complementary actions of prolonged-release metformin and glimepiride when both medicines are clinically appropriate.

This medicine is not intended for the treatment of type 1 diabetes or diabetic ketoacidosis. Use it only under medical supervision.

Key Features of Glipden-M2 1000

  • Dual-ingredient formulation: Combines Metformin Hydrochloride and Glimepiride in one tablet.
  • Prolonged-release metformin: Contains Metformin Hydrochloride 1000 mg in a prolonged-release formulation.
  • Complementary mechanisms: Both ingredients help manage blood glucose through different actions.
  • Convenient tablet dosage form: Combines two prescribed antidiabetic ingredients in a single formulation.
  • Cardries Biotic range: Part of Neuark Pharmaceutical’s pharmaceutical product portfolio.

How Metformin and Glimepiride Work

Metformin Hydrochloride primarily reduces glucose production in the liver. It also improves insulin sensitivity and helps the body use insulin more effectively.

The prolonged-release formulation is designed to release metformin gradually over time, according to its formulation characteristics.

Glimepiride belongs to the sulfonylurea class. It stimulates the pancreas to release insulin, which helps move glucose from the bloodstream into body cells.

Together, these ingredients support blood glucose management through complementary mechanisms when prescribed for an appropriate patient.

Possible Side Effects

Like other antidiabetic medicines, Metformin Glimepiride Tablets may cause side effects in some individuals. Possible effects include:

  • Low blood sugar (hypoglycaemia)
  • Nausea or vomiting
  • Diarrhoea
  • Abdominal discomfort
  • Loss of appetite
  • Bloating or other digestive disturbances

Glimepiride may cause hypoglycaemia, particularly when meals are delayed or missed. Metformin can rarely cause a serious condition called lactic acidosis.

Seek immediate medical attention if severe symptoms occur, including unusual weakness, breathing difficulty, severe abdominal discomfort, confusion or persistent vomiting. This is not a complete list of possible side effects.

Important Safety Information

Before taking Glipden-M2 1000, patients should inform their healthcare professional about their medical history and all medicines they use.

  • Use this medicine only as prescribed by a qualified healthcare professional.
  • Do not skip or delay meals, as glimepiride may increase the risk of low blood sugar.
  • Monitor blood glucose as advised by the treating healthcare professional.
  • Inform the doctor about kidney or liver problems, heart conditions or any history of serious illness.
  • Discuss alcohol consumption with the healthcare professional because it may increase certain risks associated with these medicines.
  • Inform the doctor if pregnant, planning pregnancy or breastfeeding.
  • Do not change the dose or stop treatment without medical advice.
  • Do not crush, chew or split the prolonged-release tablet unless the approved product instructions specifically permit it.
  • Report symptoms that may indicate severe hypoglycaemia or lactic acidosis promptly.

Dosage and Administration

The dosage of Glipden-M2 1000 depends on the patient’s blood glucose levels, medical condition, response to treatment and other prescribed medicines.

Patients should follow the dosage and administration instructions provided by their healthcare professional and the approved product label. Handle the prolonged-release tablet according to its specific label instructions. Do not adjust the dose independently.

Storage Instructions

  • Store according to the conditions mentioned on the product packaging.
  • Keep the tablets in their original blister packaging until use.
  • Protect the product from excessive heat and moisture.
  • Keep all medicines out of the reach of children.
  • Do not use the product after its stated expiry date.

Reviews

There are no reviews yet.

Be the first to review “Glipden-M2 1000”

Your email address will not be published. Required fields are marked *